Lauren E. Brown, Ph.D.
Affiliations: | University of California, Santa Cruz, Santa Cruz, CA, United States |
Area:
Synthetic organic chemistry; heterocyclic chemistry, bio-organic chemistryGoogle:
"Lauren Brown"Mean distance: 9.63 | S | N | B | C | P |
Parents
Sign in to add mentorNicos A. Petasis | research assistant | 2001-2003 | USC | |
Joseph P. Konopelski | grad student | 2009 | UC Santa Cruz | |
(Synthetic studies toward welwistatin, psymberin and a protective pharmaceutical.) | ||||
Scott E. Schaus | post-doc | 2009-2012 | Boston University | |
John A. Porco | research scientist | 2012-2014 | Boston University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Fallah S, Duncan D, Reichl KD, et al. (2024) A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen . Microbiology Spectrum. e0409523 |
Millimaci AM, Trilles RV, McNeely JH, et al. (2023) Synthesis of Neocannabinoids Using Controlled Friedel-Crafts Reactions. The Journal of Organic Chemistry |
Naineni SK, Cencic R, Robert F, et al. (2023) Exploring the Targeting Spectrum of Rocaglates Among eIF4A Homologs. Rna (New York, N.Y.) |
Kavouris JA, McCall LI, Giardini MA, et al. (2023) Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of infection. Frontiers in Tropical Diseases. 3 |
Shaashua L, Ben-Shmuel A, Pevsner-Fischer M, et al. (2022) BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling. Nature Communications. 13: 6513 |
Brown LE, Seitz S, Kondas AV, et al. (2022) Identification of Small Molecules with Improved Potency against Orthopoxviruses from Vaccinia to Smallpox. Antimicrobial Agents and Chemotherapy. e0084122 |
Lehman SL, Wechsler T, Schwartz K, et al. (2022) Inhibition of the translation initiation factor eIF4A enhances tumor cell radiosensitivity. Molecular Cancer Therapeutics |
Praditya DF, Klöhn M, Brüggemann Y, et al. (2022) Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication. Antiviral Research. 105359 |
Xu W, Brown LE, Porco JA. (2021) Divergent, C-C Bond Forming Macrocyclizations Using Modular Sulfonylhydrazone and Derived Substrates. The Journal of Organic Chemistry |
Chatterjee S, Yabaji SM, Rukhlenko OS, et al. (2021) Channeling macrophage polarization by rocaglates increases macrophage resistance to . Iscience. 24: 102845 |